Significant Accounting Policies (Tables) |
6 Months Ended | 9 Months Ended | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 |
Sep. 30, 2025 |
|||||||||||||||||||||||||||||||||||
| Significant Accounting Policies [Abstract] | ||||||||||||||||||||||||||||||||||||
| Schedule of Potential Common Stock Outstanding | As of December 31, 2024 and June 30, 2024, the Company had the following potential Common Stock outstanding which were not included in the calculation of diluted net loss per Common Stock because inclusion thereof would be anti-dilutive:
|
As of September 30, 2025 and December 31, 2024, the Company had the following potential Common Stock outstanding which were not included in the calculation of diluted net loss per Common Stock because inclusion thereof would be anti-dilutive:
|
||||||||||||||||||||||||||||||||||
| Schedule of Fair Value Hierarchy Our Financial Asset and Liability that were Accounted for at Fair Value on a Recurring Basis | The following table sets forth by level within the fair value hierarchy our financial asset and liability that were accounted for at fair value on a recurring basis as of September 30, 2025:
|
|||||||||||||||||||||||||||||||||||
| Schedule of Financial Liability Measured at Fair Value | The following is a reconciliation of the beginning and ending balance of the financial liability measured at fair value on a recurring basis for the nine months ended September 30, 2025:
|
|||||||||||||||||||||||||||||||||||